Abstract:Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 with staggering economic fallout and human suffering. The unique structure of SARS-CoV-2 and its underlying pathogenic mechanism were responsible for the global pandemic. In addition to the direct damage caused by the virus, SARS-CoV-2 triggers an abnormal immune response leading to a cytokine storm, culminating in acute respiratory distress syndrome and other fatal diseases that pose a significant challenge to clinicians. Therefore, potential treatments should focus not only on eliminating the virus but also on alleviating or controlling acute immune/inflammatory responses. Current management strategies for COVID-19 include preventative measures and supportive care, while the role of the host immune/inflammatory response in disease progression has largely been overlooked. Understanding the interaction between SARS-CoV-2 and its receptors, as well as the underlying pathogenesis, has proven to be helpful for disease prevention, early recognition of disease progression, vaccine development, and interventions aimed at reducing immunopathology have been shown to reduce adverse clinical outcomes and improve prognosis. Moreover, several key mutations in the SARS-CoV-2 genome sequence result in an enhanced binding affinity to the host cell receptor, or produce immune escape, leading to either increased virus transmissibility or virulence of variants that carry these mutations. This review characterizes the structural features of SARS-CoV-2, its variants, and their interaction with the immune system, emphasizing the role of dysfunctional immune responses and cytokine storm in disease progression. Additionally, potential therapeutic options are reviewed, providing critical insights into disease management, exploring effective approaches to deal with the public health crises caused by SARS-CoV-2.

Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens

Progress in SARS-CoV-2, Diagnostic and Clinical Treatment of COVID-19

The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic

SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines

Molecular Insights into the Adaptive Evolution of SARS-CoV-2 Spike Protein.

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development

What makes SARS‐CoV‐2 unique? Focusing on the spike protein

The immunology of SARS-CoV-2 infections and vaccines

The Spike Glycoprotein of Highly Pathogenic Human Coronaviruses: Structural Insights for Understanding Infection, Evolution and Inhibition.

Unraveling the structural and functional dimensions of SARS-CoV2 proteins in the context of COVID-19 pathogenesis and therapeutics

Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review

Structural review of SARS-CoV-2 antiviral targets

Structural Biology of SARS-CoV-2: Open the Door for Novel Therapies

SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies

Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Causes and Consequences of Coronavirus Spike Protein Variability

Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development

Comprehensive Role of SARS‐CoV‐2 Spike Glycoprotein in Regulating Host Signaling Pathway